RISPERDAL CONSTA 37.5 mg powder and solvent for prolonged-release suspension for injection Ireland - English - HPRA (Health Products Regulatory Authority)

risperdal consta 37.5 mg powder and solvent for prolonged-release suspension for injection

janssen-cilag ltd - risperidone - powder and solvent for suspension for injection - 37.5 milligram(s) - other antipsychotics; risperidone

RISPERDAL CONSTA 25 mg powder and solvent for prolonged-release suspension for injection Ireland - English - HPRA (Health Products Regulatory Authority)

risperdal consta 25 mg powder and solvent for prolonged-release suspension for injection

janssen-cilag ltd - risperidone - powder and solvent for suspension for injection - 25 milligram(s) - risperidone

RISPERDAL CONSTA 50 mg powder and solvent for prolonged-release suspension for injection Ireland - English - HPRA (Health Products Regulatory Authority)

risperdal consta 50 mg powder and solvent for prolonged-release suspension for injection

janssen-cilag ltd - risperidone - powder and solvent for suspension for injection - 50 milligram(s) - risperidone

Risperdal Consta New Zealand - English - Medsafe (Medicines Safety Authority)

risperdal consta

janssen-cilag (new zealand) ltd - risperidone 25mg - suspension for injection - 25 mg/2ml - active: risperidone 25mg excipient: polyglactin carmellose sodium citric acid dibasic sodium phosphate dihydrate polysorbate 20 sodium chloride sodium hydroxide water for injection - risperdal consta is indicated for the treatment of schizophrenia and other psychotic disorders. these include first episode psychoses, acute schizophrenic exacerbations, chronic schizophrenia and other psychotic conditions, in which positive symptoms (such as hallucinations, delusions, thought disturbances, hostility, suspiciousness), and/or negative symptoms (such as blunted effect, emotional and social withdrawal, poverty of speech) are prominent. risperdal consta also alleviates affective symptoms (such as depression, guilt-feelings, anxiety) associated with schizophrenia. in addition, risperdal consta also appears effective in maintaining the clinical improvement during continuation therapy in patients who have should an initial response to treatment with this agent.

Risperdal Consta New Zealand - English - Medsafe (Medicines Safety Authority)

risperdal consta

janssen-cilag (new zealand) ltd - risperidone 37.5mg - suspension for injection - 37.5 mg/2ml - active: risperidone 37.5mg excipient: polyglactin carmellose sodium citric acid dibasic sodium phosphate dihydrate polysorbate 20 sodium chloride sodium hydroxide water for injection - risperdal consta is indicated for the treatment of schizophrenia and other psychotic disorders. these include first episode psychoses, acute schizophrenic exacerbations, chronic schizophrenia and other psychotic conditions, in which positive symptoms (such as hallucinations, delusions, thought disturbances, hostility, suspiciousness), and/or negative symptoms (such as blunted effect, emotional and social withdrawal, poverty of speech) are prominent. risperdal consta also alleviates affective symptoms (such as depression, guilt-feelings, anxiety) associated with schizophrenia. in addition, risperdal consta also appears effective in maintaining the clinical improvement during continuation therapy in patients who have should an initial response to treatment with this agent.

Risperdal Consta New Zealand - English - Medsafe (Medicines Safety Authority)

risperdal consta

janssen-cilag (new zealand) ltd - risperidone 50mg - suspension for injection - 50 mg/2ml - active: risperidone 50mg excipient: polyglactin carmellose sodium citric acid dibasic sodium phosphate dihydrate polysorbate 20 sodium chloride sodium hydroxide water for injection - risperdal consta is indicated for the treatment of schizophrenia and other psychotic disorders. these include first episode psychoses, acute schizophrenic exacerbations, chronic schizophrenia and other psychotic conditions, in which positive symptoms (such as hallucinations, delusions, thought disturbances, hostility, suspiciousness), and/or negative symptoms (such as blunted effect, emotional and social withdrawal, poverty of speech) are prominent. risperdal consta also alleviates affective symptoms (such as depression, guilt-feelings, anxiety) associated with schizophrenia. in addition, risperdal consta also appears effective in maintaining the clinical improvement during continuation therapy in patients who have should an initial response to treatment with this agent.

RISPERDAL CONSTA 37.5 mg powder and solvent for prolonged-release suspension for injection Ireland - English - HPRA (Health Products Regulatory Authority)

risperdal consta 37.5 mg powder and solvent for prolonged-release suspension for injection

pco manufacturing ltd. - risperidone - suspension for injection - 37.5 milligram(s) - other antipsychotics; risperidone